In8Bio Stock Quote Today

INAB
 Stock
  

USD 1.62  0.12  8.00%   

Market Performance
0 of 100
Odds Of Distress
Less than 33
In8Bio is trading at 1.62 as of the 29th of November 2022, a 8.00 percent increase since the beginning of the trading day. The stock's open price was 1.5. In8Bio has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for In8Bio Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2022 and ending today, the 29th of November 2022. Click here to learn more.
Fiscal Year End
December
IPO Date
30th of July 2021
Category
Healthcare
ISIN
US45674E1091
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. The company has 18.75 M outstanding shares of which 44.34 K shares are currently shorted by private and institutional investors with about 0.71 trading days to cover. More on In8Bio Inc

Moving against In8Bio

-0.57GEOGeo Group Normal TradingPairCorr
-0.56APAApa Corp Potential GrowthPairCorr
-0.56JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
-0.55MRNAModerna Potential GrowthPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

In8Bio Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. In8Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding In8Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
In8Bio Inc generated a negative expected return over the last 90 days
In8Bio Inc has high historical volatility and very poor performance
In8Bio Inc may become a speculative penny stock
Net Loss for the year was (21.14 M).
In8Bio Inc currently holds about 25.74 M in cash with (18.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Roughly 26.0% of the company shares are held by company insiders
Average Analyst Recommendation
Analysts covering In8Bio report their recommendations after researching In8Bio's financial statements, talking to executives and customers, or listening in on In8Bio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering In8Bio Inc. The In8Bio consensus assessment is calculated by taking the average forecast from all of the analysts covering In8Bio.
Strong Buy2 Opinions
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of In8Bio's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
In8Bio Inc (INAB) is traded on NASDAQ Exchange in USA and employs 19 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 27.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate In8Bio's market, we take the total number of its shares issued and multiply it by In8Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. In8Bio Inc conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 18.75 M outstanding shares of which 44.34 K shares are currently shorted by private and institutional investors with about 0.71 trading days to cover. In8Bio Inc currently holds about 25.74 M in cash with (18.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Check In8Bio Probability Of Bankruptcy
Ownership
In8Bio Inc shows a total of 18.75 Million outstanding shares. In8Bio shows noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check In8Bio Ownership Details

In8Bio Stock Price Odds Analysis

What are In8Bio's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of In8Bio jumping above the current price in 90 days from now is about 84.13%. The In8Bio Inc probability density function shows the probability of In8Bio stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days In8Bio Inc has a beta of -1.0151. This usually indicates Additionally, the company has an alpha of 0.0921, implying that it can generate a 0.0921 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 1.62HorizonTargetOdds Above 1.62
15.81%90 days
 1.62 
84.13%
Based on a normal probability distribution, the odds of In8Bio to move above the current price in 90 days from now is about 84.13 (This In8Bio Inc probability density function shows the probability of In8Bio Stock to fall within a particular range of prices over 90 days) .

In8Bio Stock Institutional Holders

Institutional Holdings refers to the ownership stake in In8Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of In8Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing In8Bio's value.
InstituionSecurity TypeTotal SharesValue
Wells Fargo CompanyCommon Shares26.00.0
Wells Fargo CompanyCommon Shares24.00.0
View In8Bio Diagnostics

In8Bio Inc Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. In8Bio market risk premium is the additional return an investor will receive from holding In8Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in In8Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although In8Bio's alpha and beta are two of the key measurements used to evaluate In8Bio's performance over the market, the standard measures of volatility play an important role as well.

In8Bio Stock Against Markets

Picking the right benchmark for In8Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in In8Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for In8Bio is critical whether you are bullish or bearish towards In8Bio Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in In8Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Invested in In8Bio Inc?

The danger of trading In8Bio Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of In8Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than In8Bio. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile In8Bio Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. Note that the In8Bio Inc information on this page should be used as a complementary analysis to other In8Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for In8Bio Stock analysis

When running In8Bio Inc price analysis, check to measure In8Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8Bio is operating at the current time. Most of In8Bio's value examination focuses on studying past and present price action to predict the probability of In8Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move In8Bio's price. Additionally, you may evaluate how the addition of In8Bio to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is In8Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8Bio. If investors know In8Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
39.7 M
Return On Assets
(0.39) 
Return On Equity
(0.73) 
The market value of In8Bio Inc is measured differently than its book value, which is the value of In8Bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8Bio's value that differs from its market value or its book value, called intrinsic value, which is In8Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8Bio's market value can be influenced by many factors that don't directly affect In8Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine In8Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.